The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Zomestine 5 mg Prolonged-release Tablets

5 milligram(s) Prolonged-release tablet

Accord Healthcare Ireland Ltd.PA2315/169/001

Main Information

Trade NameZomestine 5 mg Prolonged-release Tablets
Active SubstancesOXYCODONE HYDROCHLORIDE
Strength5 milligram(s)
Dosage FormProlonged-release tablet
Licence HolderAccord Healthcare Ireland Ltd.
Licence NumberPA2315/169/001

Group Information

ATC CodeN02AA Natural opium alkaloids
N02AA05 oxycodone

Status

Authorised/WithdrawnWithdrawn
Withdrawn Date19/03/2020
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceThis product contains a substance listed in schedule 2 to the Misuse of Drugs Regulations 2017.
Marketing StatusNot marketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable List CodeIC0066-001-024
Interchangeable List DocumentPDF of Interchangeable List
« Back